Literature DB >> 10673260

Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes.

J R Lindner1, M P Coggins, S Kaul, A L Klibanov, G H Brandenburger, K Ley.   

Abstract

BACKGROUND: Albumin microbubbles that are used for contrast echocardiography persist within the myocardial microcirculation after ischemia/reperfusion (I-R). The mechanism responsible for this phenomenon is unknown. METHODS AND
RESULTS: Intravital microscopy of the microcirculation of exteriorized cremaster muscle was performed in 12 wild-type mice during intravenous injections of fluorescein-labeled microbubbles composed of albumin, anionic lipids, or cationic lipids. Injections were performed at baseline and after 30 to 90 minutes of I-R in 8 mice and 2 hours after intrascrotal tumor necrosis factor-alpha (TNF-alpha) in 4 mice. Microbubble adherence at baseline was uncommon (<2/50 high-power fields). After I-R, adherence increased (P<0.05) to 9+/-5 and 5+/-4 per 50 high-power fields for albumin and anionic lipid microbubbles, respectively, due to their attachment to leukocytes adherent to the venular endothelium. TNF-alpha produced even greater microbubble binding, regardless of the microbubble shell composition. The degree of microbubble attachment correlated (r=0.84 to 0.91) with the number of adhered leukocytes. Flow cytometry revealed that microbubbles preferentially attached to activated leukocytes. Albumin microbubble attachment was inhibited by blocking the leukocyte beta(2)-integrin Mac-1, whereas lipid microbubble binding was inhibited when incubations were performed in complement-depleted or heat-inactivated serum rather than control serum.
CONCLUSIONS: Microvascular attachment of albumin and lipid microbubbles in the setting of I-R and TNF-alpha-induced inflammation is due to their beta(2)-integrin- and complement-mediated binding to activated leukocytes adherent to the venular wall. Thus, microbubble persistence on contrast ultrasonography may be useful for the detection and monitoring of leukocyte adhesion in inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673260     DOI: 10.1161/01.cir.101.6.668

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  52 in total

1.  Optical and acoustical dynamics of microbubble contrast agents inside neutrophils.

Authors:  P A Dayton; J E Chomas; A F Lum; J S Allen; J R Lindner; S I Simon; K W Ferrara
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

Review 2.  Molecular imaging with contrast ultrasound and targeted microbubbles.

Authors:  Jonathan R Lindner
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

3.  Molecular ultrasound imaging and its potential for paediatric radiology.

Authors:  Isabel Kiessling; Jessica Bzyl; Fabian Kiessling
Journal:  Pediatr Radiol       Date:  2010-08-03

Review 4.  Molecular imaging with contrast enhanced ultrasound.

Authors:  Scott M Chadderdon; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

5.  Albumin-based microbubbles bind up-regulated scavenger receptors following vascular injury.

Authors:  Daniel R Anderson; Michael J Duryee; Rajeev K Anchan; Robert P Garvin; Michael D Johnston; Thomas R Porter; Geoffrey M Thiele; Lynell W Klassen
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

Review 6.  Preclinical lymphatic imaging.

Authors:  Fan Zhang; Gang Niu; Guangming Lu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

7.  Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles.

Authors:  Cherry C Chen; Shashank R Sirsi; Shunichi Homma; Mark A Borden
Journal:  Ultrasound Med Biol       Date:  2012-03       Impact factor: 2.998

Review 8.  [Possible target specific molecular imaging with ultrasound contrast agents].

Authors:  M Mäurer; R Linker; M Reinhardt; P Hauff
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 9.  [Ultrasound contrast agents. Pharmaceutical drug safety and bioeffects].

Authors:  M Krix; J W Jenne
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

10.  Formulation and characterization of echogenic lipid-Pluronic nanobubbles.

Authors:  Tianyi M Krupka; Luis Solorio; Robin E Wilson; Hanping Wu; Nami Azar; Agata A Exner
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.